Redeye maintains its long-term positive view of Heliospectra on the back of a Q1-report in line with expectations. The company started 2020 with strong tailwind spun from two large greenhouse orders amounting to SEK 84m. The Coronacrisis partly mitigate its positive effects on the case as we believe new sales to linger throughout 2020. We further see that the delayed down payment from Nectar Farms increases the short-term risk in the case and believe the cautions investor to await payment before acting.